Research programme: anticancer antibody-drug conjugates - Asana BioSciencesAlternative Names: ASN005
Latest Information Update: 02 Dec 2015
At a glance
- Originator Asana BioSciences
- Class Antineoplastics; Drug conjugates; Immunoconjugates; Monoclonal antibodies
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 02 Dec 2015 Preclinical trials in Cancer in USA (IV)